Logo image of QSI

QUANTUM-SI INC (QSI) Stock Fundamental Analysis

NASDAQ:QSI - Nasdaq - US74765K1051 - Common Stock - Currency: USD

1.71  -0.18 (-9.52%)

After market: 1.7 -0.01 (-0.58%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to QSI. QSI was compared to 57 industry peers in the Life Sciences Tools & Services industry. QSI has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, QSI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

QSI had negative earnings in the past year.
QSI had a negative operating cash flow in the past year.
QSI had negative earnings in each of the past 5 years.
QSI had a negative operating cash flow in each of the past 5 years.
QSI Yearly Net Income VS EBIT VS OCF VS FCFQSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -38.03%, QSI is doing worse than 77.19% of the companies in the same industry.
QSI has a worse Return On Equity (-42.72%) than 64.91% of its industry peers.
Industry RankSector Rank
ROA -38.03%
ROE -42.72%
ROIC N/A
ROA(3y)-28.29%
ROA(5y)N/A
ROE(3y)-30.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QSI Yearly ROA, ROE, ROICQSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of QSI (51.54%) is better than 61.40% of its industry peers.
The Profit Margin and Operating Margin are not available for QSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QSI Yearly Profit, Operating, Gross MarginsQSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K

More info and screens

8

2. Health

2.1 Basic Checks

QSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
QSI has more shares outstanding than it did 1 year ago.
There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QSI Yearly Shares OutstandingQSI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M
QSI Yearly Total Debt VS Total AssetsQSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

QSI has an Altman-Z score of 3.36. This indicates that QSI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of QSI (3.36) is better than 68.42% of its industry peers.
There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.36
ROIC/WACCN/A
WACC11.32%
QSI Yearly LT Debt VS Equity VS FCFQSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

2.3 Liquidity

QSI has a Current Ratio of 13.42. This indicates that QSI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of QSI (13.42) is better than 96.49% of its industry peers.
QSI has a Quick Ratio of 13.15. This indicates that QSI is financially healthy and has no problem in meeting its short term obligations.
QSI has a better Quick ratio (13.15) than 96.49% of its industry peers.
Industry RankSector Rank
Current Ratio 13.42
Quick Ratio 13.15
QSI Yearly Current Assets VS Current LiabilitesQSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

QSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.79%, which is quite good.
The Revenue has grown by 233.24% in the past year. This is a very strong growth!
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
Revenue 1Y (TTM)233.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%252.91%

3.2 Future

The Earnings Per Share is expected to grow by 3.16% on average over the next years.
Based on estimates for the next years, QSI will show a very strong growth in Revenue. The Revenue will grow by 162.83% on average per year.
EPS Next Y1.48%
EPS Next 2Y-3.17%
EPS Next 3Y0%
EPS Next 5Y3.16%
Revenue Next Year225.59%
Revenue Next 2Y190.73%
Revenue Next 3Y181.49%
Revenue Next 5Y162.83%

3.3 Evolution

QSI Yearly Revenue VS EstimatesQSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
QSI Yearly EPS VS EstimatesQSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QSI. In the last year negative earnings were reported.
Also next year QSI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QSI Price Earnings VS Forward Price EarningsQSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QSI Per share dataQSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.17%
EPS Next 3Y0%

More info and screens

0

5. Dividend

5.1 Amount

QSI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTUM-SI INC

NASDAQ:QSI (2/21/2025, 8:00:01 PM)

After market: 1.7 -0.01 (-0.58%)

1.71

-0.18 (-9.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-03 2025-03-03/amc
Inst Owners29.2%
Inst Owner Change-70.9%
Ins Owners4.23%
Ins Owner Change1.23%
Market Cap310.81M
Analysts76.67
Price Target3.49 (104.09%)
Short Float %13.33%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.61%
Min EPS beat(2)8.61%
Max EPS beat(2)16.62%
EPS beat(4)4
Avg EPS beat(4)16.98%
Min EPS beat(4)8.61%
Max EPS beat(4)30.69%
EPS beat(8)7
Avg EPS beat(8)10.35%
EPS beat(12)9
Avg EPS beat(12)2.41%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.58%
Min Revenue beat(2)-27.8%
Max Revenue beat(2)-9.37%
Revenue beat(4)2
Avg Revenue beat(4)0.29%
Min Revenue beat(4)-27.8%
Max Revenue beat(4)32.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.13%
PT rev (3m)36.67%
EPS NQ rev (1m)4.27%
EPS NQ rev (3m)4.27%
EPS NY rev (1m)1%
EPS NY rev (3m)0.77%
Revenue NQ rev (1m)-4.4%
Revenue NQ rev (3m)-4.4%
Revenue NY rev (1m)-1.76%
Revenue NY rev (3m)-22.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 137.16
P/FCF N/A
P/OCF N/A
P/B 1.48
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.72
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS0.01
BVpS1.16
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.03%
ROE -42.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.54%
FCFM N/A
ROA(3y)-28.29%
ROA(5y)N/A
ROE(3y)-30.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.4%
Cap/Sales 125.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.42
Quick Ratio 13.15
Altman-Z 3.36
F-Score4
WACC11.32%
ROIC/WACCN/A
Cap/Depr(3y)365.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
EPS Next Y1.48%
EPS Next 2Y-3.17%
EPS Next 3Y0%
EPS Next 5Y3.16%
Revenue 1Y (TTM)233.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%252.91%
Revenue Next Year225.59%
Revenue Next 2Y190.73%
Revenue Next 3Y181.49%
Revenue Next 5Y162.83%
EBIT growth 1Y2.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.67%
EBIT Next 3Y-2.33%
EBIT Next 5Y4.29%
FCF growth 1Y10.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.15%
OCF growth 3YN/A
OCF growth 5YN/A